Website profile

@Pharmacommerce

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

  • 391articles · 365d
  • 3+ day agolatest article
  • Sep 15, 2025earliest in window
  • 93%with images
  • 262avg words
articles per day
Categories
  • Economy, Business & Finance 299
  • Business & Industrial 250
  • Medical 239
  • Health & Wellness 137
  • Finance & Business 80
  • Health 60
  • Transportation 33
  • Industrial 28

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@PharmaCommerce
pharmaceuticalcommerce.com > shorts > how-pharma-will-navigate-the-ndc-12-transition

How Pharma Will Navigate the NDC-12 Transition

1+ week, 10+ hour ago   (28+ words) Pharmaceutical Commerce Liberty Dewey, DSCSA manager at Cardinal Health, breaks down the tools Pharma will use to navigate the NDC-12 transition....

@PharmaCommerce
pharmaceuticalcommerce.com > view > beyond-the-patent-cliff-why-generics-and-biosimilars-demand-different-playbooks

Beyond the Patent Cliff: Why Generics and Biosimilars Demand Different Playbooks

1+ week, 5+ day ago   (798+ words) The biopharmaceutical landscape is in the middle of its most dramatic structural reshuffling in decades. Fueled by record numbers of loss‑of‑exclusivity (LOE) events and pressure from payers to tame specialty‑drug inflation, the industry is watching two very…...

@PharmaCommerce
pharmaceuticalcommerce.com > view > faq-inside-pharmas-changing-hub-landscape

FAQ: Inside Pharma???s Changing Hub Landscape

1+ mon, 1+ week ago   (837+ words) Pharma hub services are evolving as manufacturers navigate specialty therapy growth, digital transformation, vendor transitions, and new models for patient access and support. Pharmaceutical manufacturers are reassessing how they deliver patient access and support services as therapy options increase, become…...

@PharmaCommerce
pharmaceuticalcommerce.com > shorts > can-data-prevent-the-next-drug-shortage-

Can Data Prevent the Next Drug Shortage?

1+ mon, 1+ week ago   (43+ words) Pharmaceutical Commerce Trending on Pharmaceutical Commerce To Aggregate or not to aggregation (It's not really a question) GS1-certified traceability for DSCSA-ready supply chains DSCSA Compliance Guide: What to do now that enforcement as begun...

@PharmaCommerce
pharmaceuticalcommerce.com > view > chip-parkinson-on-direct-to-patients-big-year

Chip Parkinson on Direct-to-Patient's Big Year

1+ mon, 2+ week ago   (300+ words) Pharmaceutical Commerce Pharmaceutical Commerce continues its H1 Review/H2 Outlook series, checking in with industry experts on the forecasts they made earlier this year This installment features Chip Parkinson, CEO of Gifthealth, in the first of a three-part video interview In January,…...

@PharmaCommerce
pharmaceuticalcommerce.com > view > mid-year-check-in-has-pharmas-commercial-caution-lifted-

Mid-Year Check-In: Has Pharma's Commercial Caution Lifted?

1+ mon, 3+ week ago   (515+ words) Ramarketing CEO Emma Banks revisits her "year of two halves" outlook, discussing whether 2026 has followed the same pattern and what she expects for H2. Pharmaceutical Commerce checked back in with Banks at the midpoint of 2026 to see how those observations have…...

@PharmaCommerce
pharmaceuticalcommerce.com > view > pharma-pulse-bipartisan-340b-law-introduced-and-peak-rocks-specialty-pharmacy-bet

Pharma Pulse: Bipartisan 340B Law Introduced and Peak Rock's Specialty Pharmacy Bet

2+ mon, 4+ day ago   (267+ words) In this week's Pharma Pulse, lawmakers introduce comprehensive 340B legislation, Peak Rock Capital completes its acquisition of Asembia, and new LogiPharma data shows supply chain risks across the industry. Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast bringing you the latest…...

@PharmaCommerce
pharmaceuticalcommerce.com > shorts > whats-driving-direct-to-patient-model-adoption-across-pharma-

What's Driving Direct-to-Patient Model Adoption Across Pharma?

2+ mon, 1+ week ago   (36+ words) Pharmaceutical Commerce Trending on Pharmaceutical Commerce The Hidden Architecture of Drug Shortages: Why Inventory Economics Determine Patient Access The RWE Communication Gap That's Costing Manufacturers Formulary Access...

@PharmaCommerce
pharmaceuticalcommerce.com > view > why-pharma-needs-to-rethink-its-path-to-the-patient

Q&A: Why Pharma Needs to Rethink Its Path to the Patient

3+ mon, 1+ week ago   (604+ words) Cameron Olig explains how transparency and direct access models can help pharma close the gap between drug pricing, distribution and the patient. Market access has become one of the most operationally complex and financially consequential functions in pharmaceutical commercialization. Gross-to-net…...

@PharmaCommerce
pharmaceuticalcommerce.com > view > pharma-pulse-pbm-crackdowns-and-lilly-s-3-8b-vaccine-spree

Pharma Pulse: PBM Crackdowns and Lilly’s $3.8B Vaccine Spree

3+ mon, 2+ week ago   (274+ words) In this week's Pharma Pulse, House committees advance key legislation targeting PBM kickbacks and pharmacy access, Macfarlane Packaging partners with eutecma to bring modular cold chain solutions to the UK, and more. Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast…...